Cognizin Citicoline - Therapeutic applications and current studies – QIDOSHA

Cognizin Citicoline - Therapeutic applications and current studies

November 11, 2025from Patrick Linder

What is citicoline?

Citicoline (also CDP-Choline (called) is a naturally occurring compound and precursor in the formation of phosphatidylcholine – an important component of cell membranes.[1]. When administered as a dietary supplement or medication, citicoline is rapidly absorbed in the intestine Choline and Cytidine split up[2]. Choline is an essential nutrient that u.a. is needed for the production of the neurotransmitter acetylcholine, while cytidine in the blood Uridine is converted and serves as a building block for the synthesis of membrane components in the brain[2][3]. Through these mechanisms, citicoline can be used to Health of brain cells Contributes: It supports the repair and regeneration of cell membranes and promotes the formation of neurotransmitters in the brain.[4]. Furthermore, studies suggest that the intact citicoline molecule itself neuroprotective properties might have, thus directly protecting nerve cells from damage[5].

Citicoline for cognitive disorders and dementia

One important area of application for citicoline is the support of Memory performance and the cognitive functions in old age and in the early stages of dementia. Citicoline was originally developed to treat vascular dementias (cognitive impairment caused by circulatory disorders) is being investigated. In fact, several studies suggest that there is a positive effect on mental performance can have.

A previous meta-analysis of clinical trials found z.B. a statistically significant advantage of citicoline over placebo in short-term memory tests[7]. In recent studies, citicoline has been primarily used as Supplement to established dementia medications tested.The Italian CITIRIVAD study (2017) showed that Alzheimer's patients who took citicoline in addition to their acetylcholinesterase inhibitor for 9 months at the end improved Mini-Mental State Examination (MMSE) scores had as those without citicoline[17][18].

Similarly, other retrospective analyses suggested that citicoline had a long-term effect Additional benefits on cognitive functions It could have an effect on Alzheimer's disease, as long as it is taken in combination with anti-dementia drugs.[17][18].

Results are particularly interesting when… mild cognitive impairment (MCI, mild cognitive impairment), a precursor to dementia. A recent prospective study (2023) observed patients with MCI over 9 months under citicoline therapy. The majority (around 70%) of the patients remained stable during this period. stable (no progression of cognitive decline), and almost 30% even showed so much improvement that they were again considered cognitively unremarkable.[19][20]. These results suggest that citicoline may slow down or temporarily halt the progression of mild memory disorders.

Citicoline to improve memory and attention

In addition to clinical patient groups, citicoline was also used in healthy people its nootropic (cognitively enhancing) effects are being investigated. The focus here is primarily on the Increased attention, concentration and memory in the foreground. Several placebo-controlled studies provide encouraging results:

For example, a study with healthy women of middle age (40–60 years), that already 28 days of daily citicoline intake attention significantly improved[21][22]. The participants received either 250 mg, 500 mg of citicoline (as Cognizin®), or a placebo. After four weeks, the citicoline groups showed [more/less/more] compared to the placebo group. fewer errors in an attention test (Continuous Performance Test).In particular, the 250 mg group showed significantly fewer omission errors (missed stimuli). and fewer erroneous reactions (incorrect responses to irrelevant stimuli) than the placebo group[21]. The 500 mg group also performed significantly better than the placebo group.[21]. The researchers concluded that citicoline in healthy adults Attention performance and cognitive inhibition can improve[23].

Similar findings exist in younger age groups: In a randomized study with 75 young people (male, 13–18 years) citicoline (250 or 500 mg daily for 28 days) led to a Improvement of attention and psychomotor speed compared to placebo[24]. The subjects showed faster reactions and fewer impulsive errors, with higher doses tending to produce greater effects.[24].

Effects are measurable even after a short period of use: A study with healthy adults found that Citicoline (500 mg/day) for 2 weeks already improvements in Working memory, reaction time, and alertness led[25]. Interestingly, the levels of malondialdehyde (MDA) in the blood – a biomarker for – also decreased in the citicoline study participants. oxidative stress, which normally increases under mental stress[25]. This suggests that citicoline not only improves cognitive processing, but also Effects of stress at the cellular level could mitigate.

In summary, the available studies support the use of citicoline. Supporting cognitive functions in healthy individuals can – especially Attention, concentration and possibly memory [23][24].

Citicoline as a supplement for Parkinson's disease

The Parkinson's disease It is characterized by the loss of dopaminergic neurons and leads to movement restrictions (such as tremors, stiffness, and slowness) as well as often to cognitive impairment. Citicoline promotes phospholipid synthesis in the brain and has been shown to increase dopamine release in animal studies.[26][27], The idea of using it as Additional therapy for Parkinson's disease to examine. In fact, several studies have been conducted in which citicoline was used as an adjunct to Levodopa (the standard medication that compensates for the dopamine deficiency) was given.

A systematic review (2021) summarized 7 studies with a total of 335 Parkinson's patients.The result: All The evaluated studies reported on Symptom improvements, when citicoline was used in addition to levodopa[28]. In some studies, thanks to citicoline, the required levodopa dose could even be reduced. reduced by up to 50% will be achieved without losing effectiveness[28]. Furthermore, patients taking citicoline sometimes showed significantly greater progress in typical Parkinson's symptoms such as Muscle stiffness (rigor), Slowness of movement (akinesia), Tremor, handwriting and speech[28]. An improved overall rating according to the Unified Parkinson's Disease Rating Scale (UPDRS) was documented in most studies.[29]. In addition to the motor effects, there were indications that citicoline also... cognitive functions It could have a positive effect on Parkinson's patients[30] – which is plausible, since many people with Parkinson's disease suffer from cognitive deficits, and citicoline has a memory-enhancing effect in other contexts.

Citicoline for eye health (u.a. Glaucoma)

A less well-known but interesting application of citicoline is the Eye health, especially in glaucoma (Green Star). Glaucoma is a neurodegenerative disease of the optic nerve, usually resulting from elevated intraocular pressure, which gradually leads to a narrowing of the visual field. Since citicoline has neuroprotective properties, it has been investigated whether it can... Slowing down optic nerve degeneration can.

In fact, some studies show promising results: As early as 2003, a study reported that administering 1 g of citicoline daily to glaucoma patients... Nerve conduction in the visual system improved[31]. This was measured using visual evoked potentials (VEP), where citicoline shortened signal transit times and increased amplitudes in approximately 60% of the treated eyes – an indication of improved visual pathway function.[32]. In subsequent years, various studies were conducted using oral citicoline, as well as citicoline eye drops.One systematic review (2023), The analysis of the 10 studies with a total of 424 glaucoma patients concludes that citicoline measurable neuroprotective effects can have on the visual system (z.B. improved electrophysiological parameters [33][34].

More recent clinical studies with longer observation periods are showing cautiously positive signals. In an Italian study, glaucoma patients with well-controlled intraocular pressure received over 2 years A course of citicoline therapy (oral solution, 500 mg daily, 4 months on/2 months off) was administered. The result was a Trend towards slower deterioration of the visual field in the citicoline group compared to placebo [35]. Similarly, another randomized study with 80 open-angle glaucoma patients showed a trend improved stability of the visual fields under citicoline compared to control [36][35]. The authors of these studies emphasize that larger studies are needed to clearly demonstrate the effect, but citicoline as additional neuroprotective measure which is quite plausible in the case of glaucoma – especially since Side effects did not occur[37][38].

Besides glaucoma, citicoline is also used in other conditions. Eye diseases tested, for example the diabetic retinopathy (Retinal damage in diabetes). There is initial evidence that citicoline could support retinal function.[39]. Also in the Neurology of Vision (z.B. (after optic nerve injuries or in amblyopic children) the potential benefits are being discussed. Overall, it can be said that citicoline possesses neuroprotective properties that appear to be present not only in the brain, but also in the Central nervous system of the eye make themselves noticeable.

Psychiatric disorders

Depression: In a small randomized study with 50 patients suffering from major depression, citicoline was tested as an addition to an SSRI antidepressant (citalopram).The result: The combination of citicoline + citalopram led to a faster and greater reduction of depression symptoms compared to citalopram alone[40]. After just 2, 4 and 6 weeks, depression scores were significantly lower in the citicoline group.[40]. The remission rate (complete disappearance of symptoms) was also higher with citicoline (72% vs. 44% with placebo).[41]. These preliminary data suggest that citicoline may mood-enhancing effects has or could enhance the effect of classic antidepressants.
Schizophrenia: Here, citicoline was primarily discussed in relation to the so-called Negative symptoms (z.B. The study investigated symptoms such as lack of motivation, social withdrawal, and reduced mental capacity, against which common antipsychotics are often ineffective. In an 8-week placebo-controlled study with 73 schizophrenia patients (stably stabilized on antipsychotic medication), the addition of citicoline achieved a significant improvement in negative symptoms compared to placebo[42]. On average, patients treated with citicoline showed a greater reduction on the corresponding scale (PANSS negative subscore) than the comparison group.[42]. The overall symptom score also improved significantly under citicoline.[43].
Addiction treatment: In addiction medicine, citicoline has been used primarily in the context of Cocaine addiction and Stimulants It has been researched extensively. Several studies have investigated whether citicoline can reduce drug cravings or facilitate abstinence. A notable randomized controlled trial from the University of Texas (published in 2015) specifically examined citicoline in relation to drug use. Cocaine addicts with bipolar disorder. 130 patients received either citicoline or placebo for 12 weeks in addition to their standard treatment.The result: In the first few weeks, the citicoline group showed a significantly lower cocaine consumption (demonstrated via regular urine tests) than the placebo group[45]. Further pilot studies – u.a. even at Alcohol addiction and Amphetamine abuse – indicate potential benefits[46]. Citicoline is particularly interesting in this context because it could positively influence the disturbed balance of neurotransmitters in the addicted brain (z.B. dopamine and glutamate). The results so far are promising, but not yet sufficient to firmly establish citicoline in addiction therapy. However, it is already undergoing clinical trials. z.B. in adolescents with alcohol abuse[46].

Cognizin® – a special form of citicoline

In addition to the "no-name" Citicolin, QIDOSHA now also offers the branded product. Cognizin® This is not a different active ingredient, but a protected trademark of Citicoline, the Japanese company Kyowa Hakko is produced[47]. Cognizin® is essentially pure citicoline, but combined with a special fermentation process won[48]. Cognizin is particularly stable and highly bioavailable. In practice, this means that Clinical studies preferably use Cognizin, To ensure consistent results – many of the studies mentioned in this article explicitly stated that they used Cognizin® citicoline.[49].

What else makes Cognizin special? Kyowa has conducted extensive research to evaluate Cognizin in terms of Brain health to test. Accordingly, Cognizin is available in numerous [various tests/products]. placebo-controlled studies They have been used, showing positive results for various cognitive parameters.According to statements from Kyowa's scientific director, Cognizin offers numerous benefits for mental performance – it boosts mental energy, improves memory functions, increases focus and attention span[50]. These claims are based on the aforementioned studies in healthy adults and seniors, where significant improvements were observed with Cognizin (z.B. in attention tests and memory tests)[51][19]. Furthermore, research is being conducted into the extent to which Cognizin oxidative stress in the brain can reduce it (as suggested by the decline in MDA in one study) and whether it has a beneficial effect on Response time and processing speed effects[50]. Initial findings suggest positive effects, and ongoing investigations at the cellular level are intended to determine the exact mechanisms. Mechanisms of action explore[52][53].